Optomed Oyj: Manager Laura Piila Executes Share Option Transaction

Optomed Oyj has disclosed that Laura Piila, an employee in another senior management position, has completed a transaction involving the company's financial instruments. The transaction, dated September 25, 2026, concerned Optomed Oyj's option right 2022A.

This marks Piila's initial notification of a transaction subject to disclosure requirements. The transaction was executed outside of a trading venue, and specific details regarding its nature were not provided in the initial announcement.

Optomed Oyj operates in the technology sector, focusing on diagnostic solutions for eye diseases. The company's offerings typically involve digital imaging technology for ophthalmology.

Such disclosures are mandated by regulations governing insider trading and require senior managers to report their transactions in the company's securities to ensure market transparency.